Introduction {#s1}
============

Eukaryotic cells contain several cotranslational quality-control pathways that limit the production of aberrant proteins and thereby maintain protein homeostasis. One such pathway is activated when a ribosome fails to complete translation, leading to the recruitment of specialized factors that disassemble the stalled ribosome and facilitate degradation of the nascent protein ([@bib5]; [@bib34]). A key effector of this process is the highly conserved [R]{.ul}ibosome-associated [Q]{.ul}uality control [C]{.ul}omplex (RQC), which in budding yeast comprises the E3 ubiquitin ligase Ltn1p, the ATPase Cdc48p, and the poorly characterized proteins Rqc1p and Rqc2p ([@bib4]; [@bib11]; [@bib39])---the human homologs of which are Listerin, VCP/p97, TCF25, and NEMF, respectively. The stalled translation complex is first separated into subunits by ribosome splitting factors, allowing the small ribosomal subunit (40*S*) and mRNA to be released. The RQC then recognizes and assembles on the large ribosomal subunit (60*S*) that still contains a nascent polypeptide linked to a tRNA molecule (60*S*:peptidyl--tRNA). Ltn1p facilitates ubiquitination of the nascent chain while on the 60*S* subunit, marking the incompletely synthesized protein for proteasomal degradation ([@bib2]; [@bib28]). Additionally, Rqc2p recruits charged tRNAs to the 60*S* subunit to direct elongation of the nascent protein with a [C]{.ul}arboxy-terminal [A]{.ul}lanine and [T]{.ul}hreonine extension, or CAT tail ([@bib32]).

Structural analysis of the yeast RQC, identification of the tRNA molecules that co-purify with the RQC, and biochemical characterization of failed nascent chains suggested that CAT tailing occurs on the 60*S* subunit by a unique mechanism that does not require an mRNA template or the 40*S* subunit ([@bib32]). However, many questions about the mechanism of CAT-tail synthesis and the consequences of elongating nascent polypeptides with CAT tails remain unanswered. Recent studies have suggested that one function of CAT tails is to facilitate aggregation of nascent polypeptides that fail to be ubiquitinated by Ltn1p (due to either disruptions in *LTN1* or the absence of a suitable ubiquitin acceptor). CAT tail-driven aggregation may limit the otherwise toxic effects of incomplete translation products accumulating in the cytoplasm ([@bib9]; [@bib12]; [@bib40]). However, our understanding of the functions of CAT tails in the context of an intact RQC or of the process of CAT tailing itself remains incomplete.

Previous studies have analyzed the RQC in vitro by using cell-free translation systems based on rabbit reticulocyte lysates ([@bib28]) or *Neurospora crassa* extracts ([@bib13]). In the presence of a suitable mRNA substrate, both cell-free systems recapitulate Ltn1p-dependent ubiquitination and thereby provide valuable insight into the mechanism by which Ltn1p orthologs discriminate between elongating and stalled ribosomes ([@bib28]) and the role of the N-terminal domain of Ltn1p in binding the 60*S* subunit ([@bib13]). However, neither system recapitulates Rcq2p-dependent CAT tailing, leaving important unanswered questions about how CAT tails are synthesized and whether the two principal activities of the RQC---ubiquitination by Ltn1p and CAT tailing by Rqc2p---are functionally related.

Although many studies have identified Rqc1p/TCF25 as a core component of the yeast and mammalian RQC required for nascent-chain degradation ([@bib4]; [@bib11]; [@bib29]), Rqc1p's precise structural and functional roles in the complex remain unclear. Previous work in yeast suggested that Rqc1p acts after Ltn1p to promote nascent-chain degradation. This hypothesis emerged from two lines of evidence: The presence of polyubiquitinated proteins in purified RQC depends on Ltn1p (and to a lesser extent on Rqc2p) but not on Rqc1p or Cdc48p ([@bib5]; [@bib4]); and recruitment of Cdc48p to the 60*S* subunit requires Rqc1p and nascent-chain ubiquitination ([@bib11]). However, these studies did not determine whether Rqc1p is necessary for ubiquitination of the nascent chain itself or whether recruitment of Cdc48p requires a direct interaction with Rqc1p. Therefore, the mechanism by which Rqc1p promotes nascent-chain degradation in vivo has remained unclear.

In this study, we provide an in vitro characterization of the RQC in a budding-yeast extract that uniquely recapitulates ubiquitination by Ltn1p and CAT tailing by Rqc2p, providing new insights into RQC action in promoting degradation of stalled translation products.

Results {#s2}
=======

A cell-free system that recapitulates Rqc2p-mediated nascent-chain elongation {#s2-1}
-----------------------------------------------------------------------------

Because CAT tails have thus far only been observed in *S. cerevisiae* ([@bib9]; [@bib12]; [@bib32]; [@bib40]), we used *S. cerevisiae* extracts to recapitulate Rqc2p-mediated elongation in vitro. Although *S. cerevisiae* has long been used for in vitro translation ([@bib16]; [@bib17]; [@bib27]; [@bib36]), these reactions are notoriously inefficient. Further exacerbating this problem, we aimed to program these reactions with truncated mRNA substrates that trigger quality control, which are translated less efficiently because they lack poly(A) tails that normally enhance translation. Thus, we found it necessary to first establish an optimized protocol that could reproducibly generate translation products that were detectable by immunoblotting (see Materials and methods). Critical aspects of our protocol included: (1) lysing cells with a freezer mill under cryogenic conditions rather than by bead beating in the cold; (2) minimizing the number of lysis cycles; (3) removing small molecules by dialysis rather than by size-exclusion chromatography; and (4) programming translation reactions with an mRNA encoding a small protein (i.e., 23 kDa NanoLuc luciferase), which is translated more efficiently than an mRNA encoding a larger protein (e.g., 62 kDa firefly luciferase).

To produce a substrate for the RQC, we used a truncated reporter mRNA that terminates with a sense codon (i.e., does not contain a stop codon, 3′--untranslated region (3′-UTR), or poly(A) tail). This type of mRNA substrate has been shown previously to generate a ribosome--nascent chain complex stalled at the 3′ end of the message ([@bib1]; [@bib28]). Our reporter mRNA encodes a NanoLuc luciferase (NL) protein in which the seven native lysine residues have been mutated to arginine to avoid potential confounding effects of lysine ubiquitination. The protein also includes an N-terminal 3xHA tag (which is naturally devoid of lysines) to allow detection of translation products by immunoblotting.

Programming *S. cerevisiae* in vitro translation (ScIVT) reactions with a full-length control mRNA that contains a stop codon and 3′-UTR resulted in the time-dependent accumulation of a 23 kDa product corresponding to 3xHA-NL ([Figure 1A](#fig1){ref-type="fig"}, left). In contrast, ScIVT of a truncated mRNA initially produced a \~43 kDa mass-shifted product not observed in control reactions ([Figure 1A](#fig1){ref-type="fig"}, right), which we hypothesized corresponded to a peptidyl--tRNA intermediate. Remarkably, as the reaction proceeded we observed the disappearance of the initial \~43 kDa product and concomitant accumulation of smaller mass-shifted products ranging from 23 kDa to 43 kDa ([Figure 1A](#fig1){ref-type="fig"}, right). These mass-shifted products were reminiscent of CAT-tailed species previously observed in vivo ([@bib9]; [@bib12]; [@bib32]; [@bib40]).10.7554/eLife.27949.003Figure 1.An *S. cerevisiae in vitro* translation system recapitulates synthesis of Rqc2p-dependent polypeptide extensions.(**A**) Time courses of *S. cerevisiae in vitro* translation (ScIVT) reactions. ScIVT reactions were prepared using wild-type (WT) extracts and 1 μg of either a full-length (left; includes a stop codon and 3′-UTR) or truncated (right; encodes a terminal valine residue) mRNA encoding lysine-free 3xHA-NanoLuc (3xHA-NL). At the indicated time points, aliquots of the reactions were quenched in 2X Laemmli Sample Buffer. Proteins were separated by SDS-PAGE, and HA-tagged translation products were visualized by immunoblotting. (**B**) Analyses of mass-shifted products. An ScIVT reaction was prepared using WT extracts and a lysine-free truncated mRNA substrate that also encodes a TEV cleavage site (TCS). Translation was halted after 15 or 60 min by addition of 20 mM EDTA, after which reactions were treated without (--) or with (+) TEV and/or RNase A/T1 cocktail for 60 min. Translation products were analyzed by immunoblotting as in (**A**). 'Long' and 'Short' refer to exposure times of the blots. (**C--E**) Genetic analysis of mass-shifted products. ScIVT reactions were prepared using extracts from strains of the indicated genotypes and a lysine-free truncated mRNA substrate. Reactions were performed and analyzed as in (**A**) but with less mRNA (480 ng). The species that migrate just below the peptidyl--tRNA in *rqc2Δ* extracts in (**D**) represent peptidyl--tRNA degradation products that arise due to prolonged incubation in the absence of Rqc2p. (**F**) Rescuing Rqc2p deficiency in vitro. ScIVT reactions were prepared using *rqc2Δ* extracts and a lysine-free truncated mRNA substrate. After 30 min of translation, reactions were supplemented with either protein storage buffer (--) or purified Rqc2p (WT or CAT-tailing deficient D98A at 420 nM final concentration) and indicated time points were analyzed by SDS-PAGE and immunoblotting. Dashed lines indicate where intervening lanes were removed for clarity.**DOI:** [http://dx.doi.org/10.7554/eLife.27949.003](10.7554/eLife.27949.003)10.7554/eLife.27949.004Figure 1---figure supplement 1.Purified wild-type and mutant Rqc2p.C-terminal polyhistidine-tagged Rqc2p (WT and D98A mutant) were purified as described in Materials and methods and analyzed by SDS-PAGE and Coomassie staining. 1/10th volume of the corresponding purified protein was added to ScIVT reactions.**DOI:** [http://dx.doi.org/10.7554/eLife.27949.004](10.7554/eLife.27949.004)

To further characterize the mass-shifted species, we added a sequence encoding a TEV protease cleavage site (TCS) at the 3′ end of our mRNA substrate ([@bib32]) and determined the susceptibility of the mass-shifted species to TEV protease and RNase. We reasoned that a nascent polypeptide with its C-terminus covalently linked to a tRNA molecule would be liberated by either TEV protease or RNase. In contrast, a nascent polypeptide containing an untemplated C-terminal amino-acid extension (e.g., a CAT tail) would be cleaved by TEV protease but not RNase, and a protein containing additional mass due to modifications anywhere except the C-terminus would be unaffected by either treatment. When treated with either RNase or TEV protease, the \~45 kDa intermediate observed at early time points was converted to a 25 kDa species, corresponding to the molecular weight of 3xHA-NL-TCS ([Figure 1B](#fig1){ref-type="fig"}). Given that the average molecular weight of a tRNA is \~20 kDa, these results suggest that the \~45 kDa species contained a tRNA covalently linked to the C-terminus of 3xHA-NL-TCS ('peptidyl--tRNA')---which has previously been characterized as an intermediate of the quality-control pathway ([@bib28]; [@bib33]; [@bib38]). In contrast, the heterogeneous collection of \~25--45 kDa products that accumulated at later time points were only affected by TEV protease, converting them to a discrete 25 kDa species ([Figure 1B](#fig1){ref-type="fig"}), as expected if the products originally contained additional mass downstream of the TCS (i.e., appended to the C-terminus of 3xHA-NL-TCS). Because the truncated mRNA substrate used for ScIVT contained no sequences downstream of the TCS, this additional mass was necessarily untemplated and therefore consistent with CAT tails. Notably, the prominent peptidyl--tRNA species that accumulated at early time points was largely absent after 60 min of translation ([Figure 1A and B](#fig1){ref-type="fig"}), presumably due to peptidyl--tRNA hydrolysis that occurred after untemplated elongation of the nascent chain.

In addition to being C-terminal and untemplated, another known feature of CAT tails is that their synthesis is strictly dependent on Rqc2p but not on Ltn1p or Rqc1p ([@bib9]; [@bib12]; [@bib32]; [@bib40]). To determine if the \~23--43 kDa mass-shifted species share this property, we took advantage of the genetic tractability of *S. cerevisiae* and non-essential nature of the RQC by performing ScIVT using extracts prepared from *ltn1Δ*, *rqc1Δ*, and *rqc2Δ* strains. While reactions using *ltn1Δ* and *rqc1Δ* extracts yielded all of the mass-shifted products observed when using wild-type (WT) extracts ([Figure 1C](#fig1){ref-type="fig"}), reactions using *rqc2Δ* extracts did not ([Figure 1D](#fig1){ref-type="fig"}), consistent with those species corresponding to CAT-tailed protein. However, rather than producing the expected 23 kDa 3xHA-NL protein, reactions lacking Rqc2p generated a relatively stable 43 kDa peptidyl--tRNA species, indicating a defect in peptidyl--tRNA hydrolysis. This finding suggests that in addition to facilitating the incorporation of untemplated amino acids, Rqc2p may also be involved in promoting hydrolysis of the final peptidyl--tRNA bond and thereby liberating the nascent polypeptide.

Previous biochemical and structural studies have suggested that Rqc2p engagement and subsequent CAT tailing must be preceded by ribosome splitting, which exposes the P-site tRNA and the surface of the Sarcin-Ricin loop (SRL) that are recognized by Rqc2p/NEMF ([@bib23]; [@bib30]; [@bib32]). In the case of truncated mRNAs that generate a ribosome stalled at the mRNA 3′ end with an empty A site, ribosome splitting is effected by the release-factor mimics Hbs1p and Dom34p ([@bib28]; [@bib33]). Accordingly, ScIVT of a truncated mRNA in *hbs1Δ* or *dom34Δ* extracts generated only the \~43 kDa product corresponding to an especially stable peptidyl--tRNA ([Figure 1E](#fig1){ref-type="fig"}), which is presumably protected within a stalled but intact 80*S* ribosome. Collectively, these data demonstrate that ScIVT of a truncated mRNA generates polypeptides containing untemplated Rqc2p-dependent C-terminal extensions. Although we have not been able to confirm that these extensions are composed of alanine and threonine residues (for technical reasons), we suspect that this is the case and therefore refer to the extensions as CAT tails for simplicity.

The lack of CAT-tailing activity in *rqc2Δ* extracts ([Figure 1D](#fig1){ref-type="fig"}) is consistent with previous observations that CAT tails are absent from *rqc2Δ* strains in vivo ([@bib9]; [@bib12]; [@bib32]; [@bib40]), which could reflect either a direct role for Rqc2p in CAT tailing (as suggested by structural studies) or indirect effects of *RQC2* disruption on CAT tailing. To distinguish between these possibilities, we tested whether the absence of CAT-tailing activity in *rqc2Δ* extracts could be rescued by adding purified Rqc2p to ScIVT reactions already in progress. Remarkably, the addition of exogenous Rqc2p ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}) to *rqc2Δ* extracts restored both CAT-tail synthesis and peptidyl--tRNA hydrolysis, whereas the addition of a CAT-tailing-deficient Rqc2p mutant containing the D98A substitution ([@bib32]; [@bib40]) did not promote either CAT-tail synthesis or robust peptidyl--tRNA hydrolysis ([Figure 1F](#fig1){ref-type="fig"}). These results provide direct evidence that Rqc2p is biochemically required for CAT tailing, consistent with its proposed role in recruiting alanine- and threonine-charged tRNAs to the 60*S* subunit ([@bib32]). Also, our ability to temporally separate CAT tailing from canonical translation in vitro (by the addition of exogenous Rqc2p to *rqc2Δ* extracts) provided an experimental strategy for specifically testing the requirements of CAT-tail elongation.

Mechanistic differences between CAT-tail synthesis and canonical translation {#s2-2}
----------------------------------------------------------------------------

Though previous structural studies of the RQC were instrumental in discovering CAT tailing and suggested a direct role for Rqc2p in the process ([@bib32]), the mechanism of CAT tailing has only been inferred from these data and otherwise remains poorly characterized. In particular, no published studies have investigated the extent to which CAT tailing by the 60*S* subunit is mechanistically similar to canonical elongation by the 80*S* ribosome. To address this question, we sought to examine the sensitivity of in vitro CAT tailing to a collection of well-characterized chemical inhibitors that target different sites of the ribosome or elongation factors ([Figure 2A](#fig2){ref-type="fig"}) and thereby interfere with canonical translation. Importantly, because canonical translation is required to generate the substrate for the RQC (i.e., a stalled ribosome at the post-splitting stage), it was necessary to temporally separate canonical translation from CAT tailing to isolate the effects of these inhibitors on the latter reaction. To do so, we first translated a truncated mRNA in *rqc2Δ* extracts in the absence of any inhibitors for 20 min to generate a pool of RQC substrate (60*S*:peptidyl--tRNA). We then supplemented the reactions with one of the inhibitors (at a concentration that completely inhibited canonical translation in vitro; [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}) and purified Rqc2p ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}) (or a buffer-only control) to initiate CAT-tail synthesis. Finally, we allowed the reactions to proceed for an additional 40 min before analyzing the products by immunoblotting.10.7554/eLife.27949.005Figure 2.CAT-tail synthesis is mechanistically distinct from canonical translation.(**A**) Schematics of small-molecule inhibitors that directly bind the ribosome (top) or that target the translation elongation factors eEF1a or eEF2 (bottom). Inhibitors: (A) anisomycin; (C) cycloheximide; (D2A) didemnin 2A; (DB) didemnin B; (E) emetine; (G) G418; (H) hydrolyzable GTP; (NH) non-hydrolyzable GTP-analog GMP-PCP; (P) puromycin; (S) sordarin. (\*) Denotes the peptidyl-transferase center of the 60*S* subunit. (**B--D**) Effects of small-molecule inhibitors on CAT tailing. ScIVT reactions were prepared using *rqc2Δ* extracts and a lysine-free truncated mRNA substrate. After 0 min (*t* = 0) or 20 min (*t* = 20) of translation, reactions were supplemented with either protein storage buffer (--) or purified Rqc2p at 670 nM final concentration (+) and the indicated inhibitor(s). Indicated time points ('Time (min)\') were analyzed by SDS-PAGE and immunoblotting. Additional *t* = 0 controls for the remaining inhibitors can be found in [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.27949.005](10.7554/eLife.27949.005)10.7554/eLife.27949.006Figure 2---figure supplement 1.Inhibitors and purified Rqc2p used to dissect the mechanism of CAT-tail synthesis.(**A**) Effects of small-molecule inhibitors on translation. ScIVT reactions were prepared using WT extracts and a truncated mRNA substrate, supplemented without (--) or with (+) the indicated inhibitors after 0 min (*t = 0*) of translation, and analyzed by SDS-PAGE and immunoblotting. Inhibitors: (A) anisomycin; (C) cycloheximide; (D2A) didemnin 2A; (DB) didemnin B; (E) emetine; (G) G418; (S) sordarin. Dashed lines indicate where intervening lanes were removed for clarity. (**B**) C-terminal polyhistidine-tagged Rqc2p was purified as described in Materials and methods and analyzed by SDS-PAGE and Coomassie staining. 1/10th volume of purified protein was added to ScIVT reactions. Note that this stock of protein was expressed and purified independently from the stock in [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.27949.006](10.7554/eLife.27949.006)

As predicted by the structural analyses, treatment with drugs that target the peptidyl-transferase center (PTC) of the 60*S* subunit (anisomycin and the chain terminator puromycin) completely prevented CAT-tail synthesis, providing direct evidence that the catalytic activity of the ribosome is required for CAT tailing ([Figure 2B and C](#fig2){ref-type="fig"}). Puromycin treatment also resulted in a complete collapse of the 43 kDa mass-shifted species to 23 kDa, confirming the identity of this larger species as peptidyl--tRNA ([Figure 2B](#fig2){ref-type="fig"}). In contrast to the dramatic effects of PTC inhibitors, inhibitors that target the 40*S* subunit (emetine and G418) did not inhibit CAT-tail synthesis ([Figure 2B](#fig2){ref-type="fig"}), consistent with the proposed 40*S* subunit--independent mechanism of CAT tailing. Surprisingly, cycloheximide---which binds in the E site of the 60*S* subunit and sterically clashes with the 3′ end of the deacylated tRNA during canonical translation---did not inhibit CAT tailing ([Figure 2B](#fig2){ref-type="fig"}). Cycloheximide insensitivity identifies an unanticipated feature of CAT-tail elongation that may reflect a distinct mechanism of deacylated-tRNA displacement in the absence of mRNA and the 40*S* subunit.

It was previously proposed that specific Rqc2p--tRNA interactions impart selectivity for alanine- and threonine-tRNAs to CAT-tail elongation ([@bib32]). However, it is not known if the translation elongation factors eEF1a and eEF2---which deliver aminoacyl-tRNAs to the ribosome and promote translocation, respectively---collaborate with Rqc2p to facilitate CAT-tail synthesis. Strikingly, we found that drugs targeting either eEF1a or eEF2 (didemnin variants ([@bib6]) or sordarin ([@bib20]), respectively) had no effect on CAT tailing ([Figure 2C](#fig2){ref-type="fig"}). Because many canonical translation factors are GTPases, including eEF1a and eEF2, we also examined whether CAT tailing requires GTP hydrolysis. We tested for inhibition by the non-hydrolyzable GTP analog GMP-PCP, using a similar approach as before except that at the time of Rqc2p addition we stopped translation by adding emetine to prevent ongoing translation in the GTP control reaction. Consistent with the above differences between CAT-tail elongation and translation, treatment with GMP-PCP had no impact on CAT tailing ([Figure 2D](#fig2){ref-type="fig"}), indicating that this mRNA-independent elongation mechanism does not require energy from GTP hydrolysis or the canonical activities of the translational GTPases eEF1a and eEF2. Collectively, these findings provide direct evidence that CAT tailing is a 40*S* subunit--independent, PTC-catalyzed reaction and identify key differences from canonical translation that suggest an entirely different elongation cycle.

Ltn1p- and Rqc1p-dependent ubiquitination in the yeast cell-free system {#s2-3}
-----------------------------------------------------------------------

The ability of ScIVT to recapitulate Rqc2p-dependent CAT tailing ([Figure 1](#fig1){ref-type="fig"}) led us to explore whether this system also recapitulates the other key activity of the RQC, Ltn1p-dependent nascent-chain ubiquitination. Initial experiments comparing a lysine-containing truncated reporter mRNA to a lysine-free version revealed a faint smear of high-molecular-weight (HMW) products (\~50--115 kDa) unique to the lysine-containing reporter ([Figure 3A](#fig3){ref-type="fig"}, compare lanes 1 and 4). We reasoned that these HMW products were likely ubiquitinated proteins because lysine residues are the canonical ubiquitination sites ([@bib26]). However, because ScIVT extracts contain many ubiquitin ligase activities and a finite pool of endogenous ubiquitin, we suspected that Ltn1p-dependent ubiquitination of the reporter protein (which occurs late in the reactions) might have been limited by the amount of ubiquitin available to Ltn1p. Indeed, supplementing ScIVT reactions with exogenous ubiquitin resulted in enhanced accumulation of the lysine-dependent HMW products ([Figure 3A](#fig3){ref-type="fig"}). Treatment of ubiquitin-supplemented reactions with TEV protease or RNase did not fully collapse the HMW species as it did for CAT-tailed species ([Figure 3B](#fig3){ref-type="fig"}), consistent with the HMW species containing ubiquitin-modified residues rather than simply having exceptionally long CAT tails. To directly demonstrate that these HMW species contained ubiquitin, we translated truncated mRNAs (with or without lysines) in the presence of exogenous Myc-tagged ubiquitin and purified the reporter protein under denaturing conditions, followed by immunoblotting to detect Myc-tagged ubiquitin. In reactions conducted with WT extracts, we readily detected Myc-tagged ubiquitin within the purified HMW species ([Figure 3C](#fig3){ref-type="fig"}, fourth lanes in left and right panels).10.7554/eLife.27949.007Figure 3.*S. cerevisiae* in vitro translation recapitulates Ltn1p-mediated ubiquitination.(**A**) Effects of adding exogenous ubiquitin to ScIVT reactions. ScIVT reactions conducted in WT extracts with lysine-containing (+Lys) or lysine-free (--Lys) truncated mRNA were supplemented with the indicated concentrations of recombinant ubiquitin, incubated for 60 min, and then analyzed by SDS-PAGE and immunoblotting. Dashed line indicates where intervening lanes were removed for clarity. (**B**) Analysis of high-molecular-weight smears. RNase A/T1 and TEV protease treatment of ScIVT reactions programmed with lysine-containing truncated mRNA encoding a TEV cleavage site (TCS) in WT extracts supplemented with 100 μM recombinant ubiquitin. Translation was halted after 60 min by addition of 20 mM EDTA, after which reactions were treated without (--) or with (+) TEV and/or RNase A/T1 for 60 min, and then analyzed by SDS-PAGE and immunoblotting. Note that due to long incubations (120 mins), very little peptidyl--tRNA persists in these reactions. (**C**) Isolation and detection of ubiquitinated ScIVT products. ScIVT reactions were conducted with 1.2 μg of truncated mRNA (3xHA-10xHis-NanoLuc, with or without lysines or His tag as indicated) in extracts prepared from strains of the indicated genotypes and supplemented with 10 μM recombinant Myc-ubiquitin. For input samples (bottom panels), one-third of the ScIVT reaction was quenched with 2X Laemmli Sample Buffer. For Ni-NTA-purified samples (top panels), two-thirds of the ScIVT reaction was quenched with 6 M guanidine-HCl. For SDS-PAGE, 30% of input samples and 100% of Ni-NTA-purified samples were separated on 12% NuPAGE gels and translation products were visualized by immunoblotting with antibodies indicated at left. Dashed lines indicate where intervening lanes were removed for clarity.**DOI:** [http://dx.doi.org/10.7554/eLife.27949.007](10.7554/eLife.27949.007)

As expected, we did not observe ubiquitination of the reporter protein in reactions performed with *ltn1Δ* extracts ([Figure 3C](#fig3){ref-type="fig"} and [Figure 4A](#fig4){ref-type="fig"}), consistent with Ltn1p being the responsible E3 ubiquitin ligase. The addition of purified Ltn1p to *ltn1Δ* extracts restored ubiquitination, while the addition of purified Ltn1p containing the W1542E substitution---a RING domain mutant that does not support protein turnover in vivo ([@bib2])---did not ([Figure 4A](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). These results demonstrate that the lack of ubiquitination in *ltn1Δ* extracts is a direct consequence of the absence of Ltn1p rather than an indirect effect. Collectively, these results demonstrate that in addition to Rqc2p-dependent CAT tailing the ScIVT system we established also recapitulates Ltn1p-dependent ubiquitination, as previously shown for lysates derived from *N. crassa* and rabbit reticulocytes ([@bib13]; [@bib28]).10.7554/eLife.27949.008Figure 4.Rqc1p and CAT tailing contribute to Ltn1p-dependent ubiquitination.(**A--C**) Genetic analysis of RQC-mediated ubiquitination in ScIVT. ScIVT reactions were prepared using extracts from strains of the indicated genotype, a lysine-containing truncated mRNA substrate, ubiquitin storage buffer (--) or 100 μM recombinant ubiquitin (+), and either protein storage buffer (--) or the indicated purified proteins (+): Ltn1p at 130 nM, Rqc1p at 70 nM, and Rqc2p at 420 nM final concentration. (**D**) ScIVT reactions were conducted using *rqc2Δ* extracts, a lysine-free or lysine-containing truncated mRNA substrate, and 100 μM exogenous ubiquitin. After 0 min (*t* = 0) or 30 min (*t* = 30) of translation, all reactions were supplemented with an equal volume of 'mock ScIVT' (i.e., without mRNA) containing 1.34 μM purified Rqc2p, 100 μM exogenous ubiquitin, and the indicated inhibitor(s). Indicated time points ('Time (min)\') were analyzed by SDS-PAGE and immunoblotting. 'Long' and 'Short' refer to exposure times of the blots.**DOI:** [http://dx.doi.org/10.7554/eLife.27949.008](10.7554/eLife.27949.008)10.7554/eLife.27949.009Figure 4---figure supplement 1.Purified Ltn1p and Rqc1p.C-terminal polyhistidine-tagged Ltn1p (WT and W1542E mutant) and Rqc1p were purified as described in Materials and methods and analyzed by SDS-PAGE and Coomassie staining. 1/10th volume of the corresponding purified protein was added to ScIVT reactions.**DOI:** [http://dx.doi.org/10.7554/eLife.27949.009](10.7554/eLife.27949.009)10.7554/eLife.27949.010Figure 4---figure supplement 2.Impact of excess Ltn1p on ubiquitination in *rqc1Δ* extracts.ScIVT reactions were conducted as in [Figure 4A--C](#fig4){ref-type="fig"} except that 100 μM exogenous ubiquitin was present in all reactions.**DOI:** [http://dx.doi.org/10.7554/eLife.27949.010](10.7554/eLife.27949.010)10.7554/eLife.27949.011Figure 4---figure supplement 3.Impact of CAT-tailing inhibition on ubiquitination.ScIVT reactions were conducted as in [Figure 4D](#fig4){ref-type="fig"}, except all reactions were performed with lysine-containing mRNA and 'mock ScIVT' containing either protein storage buffer (--) or 1.34 μM purified Rqc2p (+).**DOI:** [http://dx.doi.org/10.7554/eLife.27949.011](10.7554/eLife.27949.011)

Unexpectedly, we did not detect any Ltn1p-dependent ubiquitination of the reporter protein in *rqc1Δ* extracts ([Figure 3C](#fig3){ref-type="fig"}). The addition of purified Rqc1p ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}), however, fully rescued ubiquitination in *rqc1Δ* extracts ([Figure 3C](#fig3){ref-type="fig"} and [Figure 4B](#fig4){ref-type="fig"}). Increasing the concentration of Ltn1p in the reaction did not bypass the requirement for Rqc1p in ubiquitination ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). These observations suggest that Rqc1p is directly involved in nascent-chain ubiquitination. Such a role is consistent with the fact that *LTN1* deletion phenocopies *RQC1* deletion in both the accumulation of stalling reporters in vivo and, more broadly, in their correlated set of genetic interactions ([@bib4]; [@bib11]). Although TCF25/Rqc1p was previously reported to be dispensable for Listerin/Ltn1p-mediated ubiquitination of purified 60*S*-bound stalled nascent chains ([@bib29]), the stringent purification of ribosome--nascent chain complexes in that study might have removed factors that otherwise impose a requirement for Rqc1p/TCF25 (e.g., chaperones that protect the nascent chain). Our results support a model in which Rqc1p directly promotes Ltn1p-mediated ubiquitination of the nascent chain via a mechanism that remains to be determined.

Interplay between CAT tailing and ubiquitination {#s2-4}
------------------------------------------------

Previous studies have shown that a CAT-tailing-deficient mutant of Rqc2p preserves degradation of stalled nascent chains ([@bib32]) and that in vitro reconstitution of Listerin/Ltn1p-mediated ubiquitination does not strictly require NEMF/Rqc2p ([@bib29]; [@bib28]). Together, these studies suggested that CAT tailing is dispensable for degradation of the assayed reporter constructs. Based on these results and structural data, it was proposed that Rqc2p indirectly contributes to ubiquitination by recognizing the aberrant 60*S*:peptidyl--tRNA complex, stabilizing Ltn1p on the 60*S* subunit, and sterically preventing the 40*S* subunit from rejoining ([@bib30]). Together with the minimal impact of *LTN1* disruption on CAT tailing in vivo ([@bib9]; [@bib12]; [@bib32]; [@bib40]) and in vitro ([Figure 1](#fig1){ref-type="fig"}), these studies led to a model in which ubiquitination by Ltn1p and CAT tailing by Rqc2p are independent activities of the RQC ([@bib18]).

The unique ability of our ScIVT system to recapitulate both activities of the RQC, combined with its genetic tractability, allowed us to directly test this model in vitro. Consistent with the proposed scaffolding function of Rqc2p in ubiquitination, disruption of *RQC2* abrogated nascent-chain ubiquitination by Ltn1p ([Figure 3C](#fig3){ref-type="fig"} and [Figure 4C](#fig4){ref-type="fig"}), and addition of wild-type Rqc2p rescued ubiquitination ([Figure 4C](#fig4){ref-type="fig"} and [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Unexpectedly, however, the addition of CAT-tailing-deficient (D98A) Rqc2p to *rqc2Δ* extracts only partially rescued ubiquitination ([Figure 4C](#fig4){ref-type="fig"}). Similarly, reactions using extracts containing endogenously expressed Rqc2p(D98A) as the only *RQC2* gene product yielded minimal ubiquitinated protein ([Figure 3C](#fig3){ref-type="fig"}). To rule out the possibility that the effect of the D98A substitution on ubiquitination was due to disruption of the known scaffolding function of Rqc2p, we took an alternative approach to inhibit CAT tailing in the context of wild-type Rqc2p. As observed in the Rqc2p(D98A) experiments, preventing CAT tailing of stalled nascent chains---in this case with anisomycin treatment ([Figure 2C](#fig2){ref-type="fig"})---substantially reduced ubiquitination ([Figure 4D](#fig4){ref-type="fig"} and [Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}). These results suggest that Rqc2p not only provides structural support for Ltn1p but also that CAT tailing directly enhances Ltn1p-dependent ubiquitination of at least some substrates (see Discussion). Collectively, our in vitro analyses reveal that all three components of the RQC---Ltn1p/Listerin, Rqc1p/TCF25, and Rqc2p/NEMF---contribute to ubiquitination of the nascent chain.

Discussion {#s3}
==========

We have shown that establishing a cell-free system that recapitulates both CAT tailing and ubiquitination opens new opportunities to explore how the fully functional RQC promotes clearance of aberrant translation products. Our analyses reveal that Rqc2p-mediated nascent-chain elongation is mechanistically distinct from canonical translation, that ubiquitination of the nascent polypeptide requires both Ltn1p and Rqc1p, and that the ubiquitination and CAT-tailing activities of the RQC are coupled through a mutual requirement for active Rqc2p ([Figure 5](#fig5){ref-type="fig"}).10.7554/eLife.27949.012Figure 5.Model for CAT tailing and ubiquitination of stalled nascent chains.When an 80*S* ribosome stalls during translation, splitting factors recognize the stalled translation complex to facilitate dissociation of the 40*S* subunit and mRNA. Ltn1p, Rqc2p, and Rqc1p (unknown location indicated by '?\') bind the resulting 60*S*:peptidyl--tRNA complex. Together with the peptidyl-transferase center of the 60*S* subunit, Rqc2p facilitates elongation of the stalled nascent chain with a CAT tail by recruiting alanine- and threonine-charged tRNAs to the A site. If the nascent chain contains a lysine residue (red circle) located within the vicinity of the Ltn1p RING domain (or potentially hidden inside the ribosome exit tunnel), CAT tailing and Rqc1p enhance or facilitate Ltn1p-mediated ubiquitination of the nascent chain, respectively, for subsequent proteasomal degradation (green box). If the nascent chain does not contain any lysine residues (or contains lysine residues that are too distant from the Ltn1p RING domain), CAT tails may promote aggregation of incompletely synthesized proteins (red box). In both instances, Rqc2p activity promotes hydrolysis of the peptidyl--tRNA linkage and liberation from the 60*S* subunit.**DOI:** [http://dx.doi.org/10.7554/eLife.27949.012](10.7554/eLife.27949.012)

The key benefit of an in vitro system to study CAT tailing is the ability to perform experiments that would be intractable in vivo. Indeed, a major difficulty in studying CAT tailing is that it utilizes some of the same machinery as canonical translation (i.e., the 60*S* subunit) and requires a substrate that is generated by canonical translation, making it difficult to perturb CAT tailing specifically. By temporally separating the translation- and CAT-tailing-phases of in vitro reactions, we overcame this obstacle and specifically tested the sensitivity of the CAT-tailing reaction to a wide range of well-characterized ribosome and translation inhibitors. These analyses revealed that aside from requiring the catalytic PTC of the ribosome, CAT tailing is otherwise fundamentally different from translation elongation in ways that could not have been fully anticipated from previous studies ([Figure 2](#fig2){ref-type="fig"}). In particular, our findings that CAT tailing does not require the canonical activities of the elongation factors or energy from GTP hydrolysis suggest a unique mechanism of elongation. Reexamining 60*S*:RQC structures ([@bib30]; [@bib32]), we noted that the network of interactions between Ltn1p/Rqc2p and the 60*S* subunit overlaps with the ribosome-binding sites of eEF1a ([@bib31]) and eEF2 ([@bib37]). The overlap in binding sites indicates that either eEF1a/eEF2 are dispensable for CAT tailing, or that eEF1a/eEF2 and the RQC interact transiently with the 60*S* subunit during elongation. Our findings favor the former model and suggest that Rqc2p directly recruits charged tRNAs with its selective tRNA-binding activity ([@bib32]), without the involvement of eEF1a. Following peptide-bond formation by the 60*S* subunit, the A/P and P/E tRNAs may spontaneously translocate in the absence of interactions with an mRNA template or 40*S* subunit; whereas during canonical translation such interactions impose an energy requirement for translocation that is fulfilled by the GTPase activity of eEF2. Given that CAT tailing was proposed to occur on the 60*S* subunit ([@bib32]), we predicted that all translation inhibitors that bind the 60*S* subunit would inhibit CAT-tail synthesis. However, we found that CAT tailing was not inhibited by cycloheximide, suggesting that the deacylated tRNA may rapidly dissociate from the 60*S* subunit following peptidyl transfer.

Together, these findings suggest that a minimal set of factors---a 60*S*:peptidyl--tRNA complex, charged alanine and threonine tRNAs, and Rqc2p---may be sufficient for CAT-tail synthesis. In 1969, Monro demonstrated that in the presence of certain alcohols, isolated bacterial 50*S* ribosomal subunits could catalyze polymerization from aminoacyl-tRNAs in the absence of an mRNA template and 30*S* subunits ([@bib24]). Thus, it is conceivable that Rqc2p may stimulate nascent-chain elongation much as in Monro's minimal prokaryotic system. Many questions remain about Rqc2p dynamics during CAT tailing, including whether a single molecule of Rqc2p remains on the 60*S* subunit for successive cycles of peptide-bond formation or whether each cycle of elongation requires binding by a new Rqc2p--tRNA complex.

CAT-tail synthesis eventually terminates by hydrolysis of the peptidyl--tRNA linkage, which is presumably needed to release the CAT-tailed nascent chain from the 60*S* subunit for its destruction by the proteasome. Indeed, one critical function of CAT tailing might be to provide a mechanism of termination in the absence of a stop codon. The wide range of CAT-tail lengths observed both in vivo ([@bib9]; [@bib12]; [@bib32]; [@bib40]) and in vitro suggests that termination is a stochastic process. Furthermore, our finding that peptidyl--tRNA intermediates are relatively stable in vitro in the absence of Rqc2p ([Figure 1D and F](#fig1){ref-type="fig"}, [Figure 2](#fig2){ref-type="fig"}, and [Figure 4C](#fig4){ref-type="fig"}) indicates a potentially direct role of Rqc2p in the termination reaction. These observations lead to a model for CAT-tailing termination in which Rqc2p recruits a termination factor to the 60*S* subunit in a stochastic manner during the process of elongation. Because Rqc2p interacts with A-site tRNAs at a site distant from the acceptor stem ([@bib32]), it is possible that the 'termination factor' is an uncharged alanine- or threonine-tRNA ([@bib7]; [@bib41]). Alternatively, Rqc2p might interact with the canonical termination factor eRF1 or another protein with peptidyl--tRNA hydrolase activity to facilitate termination.

Taking advantage of the fact that our extracts also recapitulated Ltn1p-dependent ubiquitination, we found that Rqc1p plays a critical role in nascent-chain ubiquitination in vitro ([Figure 3C](#fig3){ref-type="fig"} and [Figure 4B](#fig4){ref-type="fig"}). This direct role of Rqc1p in ubiquitination contrasts with its previously suggested role in recruiting Cdc48p downstream of ubiquitination ([@bib4]; [@bib11]). Nevertheless, our discovery that ubiquitination in vitro is as dependent on Rqc1p as it is on the E3 ligase Ltn1p is consistent with the fact that yeast strains lacking Rqc1p and Ltn1p have very similar phenotypes and genetic interaction profiles, suggesting a similar molecular defect in these strains ([@bib4]). We speculate that Rqc1p may facilitate ubiquitination by positioning the nascent chain in proximity to the Ltn1p RING domain, by promoting binding of the E2 ubiquitin-conjugating enzyme, or by activating Ltn1p's E3 ligase activity on the 60*S* subunit.

With a system that uniquely recapitulates both nascent-chain elongation by Rqc2p and ubiquitination by Ltn1p, we discovered that Rqc2p can elongate the nascent chain to enhance ubiquitination, rather than just providing structural support for Ltn1p binding to the 60*S* subunit ([Figure 3C](#fig3){ref-type="fig"} and [Figure 4C](#fig4){ref-type="fig"}). This finding was surprising given that previous studies have shown that a CAT-tailing-deficient mutant of Rqc2p preserves degradation of aberrant nascent chains in yeast cells ([@bib32]) and that in vitro reconstitution of Listerin/Ltn1p-mediated ubiquitination does not strictly require NEMF/Rqc2p ([@bib29]). How can we reconcile these findings? Structural studies of full-length Listerin/Ltn1p on the 60*S* subunit localized its RING domain (which binds an E2 ubiquitin-conjugating enzyme) near the ribosomal exit tunnel ([@bib30]), poised to facilitate ubiquitination of lysine residues close to or recently emerged from the tunnel. The physical tethering of the RING domain near the exit tunnel suggests that Ltn1p may not be able to access more distantly positioned lysines in the nascent polypeptide, nor can the most recently translated lysines---contained within the 30--60-amino-acid long exit tunnel ([@bib22])---be accessed by Ltn1p until their emergence. Our observations lead to a model in which Ltn1p can only ubiquitinate a spatially restricted set of lysines, while CAT tailing enables access to other lysines---as previously proposed ([@bib5]; [@bib35]) and recently demonstrated in vivo ([@bib21]). We reason that the few nascent chain RQC substrates previously studied in vivo could be degraded in a CAT-tailing-independent manner ([@bib9]; [@bib12]; [@bib32]; [@bib40]) due to native lysines being fortuitously positioned proximal to the Ltn1p RING domain.

Recent studies in budding yeast have demonstrated that CAT tails mediate formation of detergent-insoluble aggregates when the nascent chain cannot be degraded due to its limited ubiquitination potential or due to inactivation of Ltn1p ([@bib9]; [@bib12]; [@bib40]). In the context of a fully intact RQC, however, our findings suggest that CAT tailing and ubiquitination are interdependent activities. Elongation of the nascent chain with CAT tails can result in two outcomes: positioning lysine residues proximal to the Ltn1p RING domain for efficient ubiquitination; or distancing lysine residues from the Ltn1p RING domain, making ubiquitination less efficient. Thus, CAT tailing and ubiquitination must be tightly coordinated to promote nascent-chain degradation and to avoid, where possible, aggregate formation and the detrimental sequestration of cytosolic chaperones. These studies collectively suggest that rather than being the primary role of CAT tails, aggregation is more likely a backup pathway to mitigate the toxic effects of stalled polypeptides that cannot be efficiently ubiquitinated and degraded ([Figure 5](#fig5){ref-type="fig"}). A notable distinction between the aggregation- and ubiquitination-promoting functions of CAT tails is that the former depends on the alanine/threonine composition of the CAT tail ([@bib9]), while the latter depends on the process of CAT tailing itself.

While CAT tailing has yet to be reported in metazoans, the conservation of Rqc1p/TCF25, Rqc2p/NEMF, and Ltn1p/Listerin---including critical residues that we mutated in this study---suggest that both RQC activities are conserved and together provide a means of protecting cells against the accumulation of faulty translation products. Ltn1p-dependent ubiquitination has been detected in rabbit reticulocyte extracts, so a CAT-tailing-dependent mechanism to facilitate ubiquitination of inaccessible lysine residues likely operates in metazoans as well. Underscoring the importance of this quality-control mechanism in maintaining proteostasis, mutations in the mammalian homologs of *HBS1* ([@bib19]) and *LTN1* ([@bib10]) cause neurodegeneration in mice.

With our newfound insights, the similarities between the bacterial tmRNA system and the eukaryotic RQC become even more striking than previously appreciated. In certain bacteria, a stalled ribosome is rescued by the recruitment of a hybrid tRNA/mRNA-like molecule (tmRNA) to the empty A-site of the ribosome, leading to translation of a tmRNA-encoded C-terminal degron that includes a dedicated stop codon ([@bib25]). In this way, stalled nascent chains are marked for degradation and translation can terminate even when the mRNA template lacks a stop codon. The RQC fulfills these same functions but in a different manner that is compatible with the ubiquitin-proteasome system: Stalled nascent chains are marked for degradation by ubiquitination (in certain cases facilitated by CAT tailing), and translation can terminate without a stop codon with the help of Rqc2p. Thus, both mechanisms involve a ribosome-catalyzed peptidyl-transferase reaction that adds a C-terminal extension that is not templated by the parent mRNA molecule. The addition of the C-terminal extension, moreover, facilitates peptidyl--tRNA hydrolysis and nascent-chain release either directly (tmRNA) or indirectly (RQC) to promote degradation. These functional similarities between the tmRNA system and the RQC---despite not sharing any related factors other than the ribosome---provide a striking example of convergent evolution that emphasizes the physiological importance of discarding incompletely synthesized proteins and recycling the translation machinery.

Materials and methods {#s4}
=====================

Yeast strain construction {#s4-1}
-------------------------

*Saccharomyces cerevisiae* strains used in this study were derived from BY4741 (*MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0*) and are listed in [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}. Yeast transformations were performed using the PEG--lithium acetate method ([@bib15]). To generate gene knockouts, the entire coding sequence of the gene of interest was replaced with the *URA3* cassette of pRS416. Strains containing point mutations at endogenous loci were generated from *URA3*-disrupted strains by transformation with PCR fragments encoding the mutant gene of interest and 5-FOA counterselection ([@bib3]). Transformants were screened by PCR to identify integrants, which were subsequently verified by PCR and Sanger sequencing of the entire integrated cassette.

Preparation of mRNA for in vitro translation {#s4-2}
--------------------------------------------

pcDNA3.1(+) (Thermo Fisher Scientific, Waltham, MA) was modified using Gibson Assembly Master Mix (New England Biolabs, Ipswich, MA) and appropriate DNA fragments according to the Gibson assembly method ([@bib14]) to generate pBAO1124, which contains (in order): T7 promoter, 46-nt 5′-UTR lacking any AUG or near-AUG codons (i.e., NUG, ANG, or AUN, where N is any nucleotide), 3xHA-NanoLuc luciferase ORF, 56-nt 3′-UTR, and 50-nt poly(A) sequence. RNAs were generated by run-off transcription with T7 RNA Polymerase using the MEGAscript T7 Transcription Kit (Thermo Fisher Scientific) according to the manufacturer's instructions using PCR-amplified DNA templates derived from pBAO1124 or its variants (DNA sequences are provided in [Supplementary file 2](#SD2-data){ref-type="supplementary-material"}). Transcription reactions were terminated by addition of ammonium acetate stop solution. RNA was extracted with neutral phenol:chloroform:isoamyl alcohol (25:24:1) (Sigma, St. Louis, MO), precipitated with ethanol, and resuspended in nuclease-free water. A 5′−7-methylguanosine cap was added to RNA post-transcriptionally using the Vaccinia Capping System (New England Biolabs). Capping reactions were desalted using Micro Bio-Spin Columns with Bio-Gel P-30 (Bio-Rad, Hercules, CA) before RNA was extracted with phenol, precipitated with ethanol, and resuspended in nuclease-free water.

*S. cerevisiae* in vitro translation extract preparation {#s4-3}
--------------------------------------------------------

*S. cerevisiae* strains were grown overnight to saturation in rich YPAD media, diluted the next morning to OD~600~ 0.2 in a total volume of 1 L YPAD, and harvested at OD~600~1.4--1.8 by centrifugation at 3500 rpm for 6 min at 4°C. The cell pellet was washed with water and resuspended in lysis buffer A (30 mM HEPES-KOH pH 7.4, 100 mM KOAc, 2 mM Mg(OAc)~2~, 2 mM DTT, and cOmplete mini EDTA-free protease inhibitor cocktail \[Roche, Switzerland\]) using 1 ml per 6 g of wet cell pellet. The cell slurry was dripped into liquid nitrogen to produce frozen pellets, which were then pulverized using a 6970EFM Freezer/Mill (SPEX SamplePrep, Metuchen, NJ) by three cycles of 12 Hz agitation for 1.5 min with cooling for 2 min after each cycle. The resulting 'grindate' was combined with an equal volume of pre-chilled lysis buffer A (i.e., 1 ml per 1 g of grindate) and allowed to thaw on ice. Cell debris was cleared by sequential centrifugation at 4°C at 1000 g for 5 min, 1350 g for 5 min, 14000 g for 30 min, and finally 14000 g for an additional 10 min. The clarified lysate was dialyzed twice for 2 hr against 250 ml lysis buffer A (except without protease inhibitor cocktail) using 3500 MWCO cassettes (Thermo Fisher Scientific \#87722). After dialysis, lysates were flash frozen in 50 μl aliquots in liquid nitrogen and stored at --80°C.

*S. cerevisiae* in vitro translation {#s4-4}
------------------------------------

Endogenous mRNAs in thawed extracts were degraded by treatment with 0.3 U/μl micrococcal nuclease (MNase) and 480 μM CaCl~2~ for 10 min at room temperature, followed by addition of 2 mM EGTA and transfer to ice. ScIVT reactions were initiated by adding m^7^G-capped RNA (40 ng per μl of reaction volume) to MNase-treated yeast extracts and incubating at 25°C for up to 90 min. Final concentrations of reaction components were 48.67% (v/v) MNase-treated yeast extract, 22 mM HEPES-KOH (pH 7.4), 120 mM potassium acetate, 1.5 mM magnesium acetate, 0.75 mM ATP, 0.1 mM GTP, 0.04 mM each amino acid, 1.7 mM DTT, 25 mM creatine phosphate, 0.34 μg/μl creatine kinase, 0.14 U/μl SUPERase•In RNase Inhibitor (Thermo Fisher Scientific), and 0.16X cOmplete mini EDTA-free protease inhibitor cocktail (Roche). Where indicated, reactions also included 10 or 100 μM recombinant human ubiquitin or Myc-ubiquitin (Boston Biochem, Cambridge, MA). Reactions were halted by transferring to ice or by adding an equal volume of 2X Laemmli Sample Buffer (Bio-Rad). The results shown for all ScIVT experiments are representative of at least two technical replicates (i.e., experiments conducted with independently prepared reagents).

Inhibitor concentrations {#s4-5}
------------------------

Concentrated stock solutions are diluted 1:10 into the ScIVT reactions. For example: 1 μl of 2 mM Anisomycin (in 5% DMSO) was added to a 10 μl ScIVT reaction. All stock solutions should be dissolved in water (or diluted with water) as ScIVT reactions cannot tolerate 100% DMSO or ethanol. Small molecules were used at the following final concentrations:

-   \(A\) anisomycin: 200 μM \[stock = 2 mM in 5% DMSO\]

-   \(C\) cycloheximide: 300 μM \[stock = 3 mM in water\]

-   (D2A) didemnin 2A: 50 μM \[stock = 500 μM in 5% DMSO\]

-   (DB) didemnin B: 50 μM \[stock = 500 μM in 5% DMSO\]

-   \(E\) emetine: 400 μM \[stock = 4 mM in water\]

-   \(G\) G418: 200 μM \[stock = 2 mM in water\]

-   \(H\) hydrolyzable GTP: 500 μM (i.e. 5x excess of GTP in reaction) \[stock = 5 mM in water\]

-   (NH) non-hydrolyzable GTP-analog GMP-PCP: 500 μM (i.e. 5x excess of GTP in reaction) \[stock = 5 mM in water\]

-   \(P\) puromycin: 500 μM \[stock = 5 mM in water\]

-   \(S\) sordarin: 10 μM \[stock = 100 μM in water\]

Denaturing purification of ScIVT products {#s4-6}
-----------------------------------------

30 μl ScIVT reactions were assembled with 1.2 μg 3xHA-10xHis-NL mRNAs and 10 μM recombinant Myc-ubiquitin (Boston Biochem) and incubated at 25°C for 1 hr. For input samples, 10 μl was removed and quenched in an equal volume of 2X Laemmli Sample Buffer. For Ni-NTA-purified samples, the remaining 20 μl was quenched by addition of denaturing buffer (6 M guanidine-HCl, 50 mM Tris pH 7.8, 300 mM KCl, 10 mM imidazole, 0.1% NP-40, 5 mM β-mercaptoethanol \[βME\]), and then incubated with 10 μl of pre-washed Ni-NTA Magnetic Agarose Beads (Qiagen, Germany) at 4°C overnight with end-over-end rotation. Beads were washed three times with wash buffer I (denaturing buffer except 500 mM KCl) and three times with wash buffer II (denaturing buffer except 50 mM KCl and no guanidine-HCl), each for 5 min at room temperature. Bound proteins were eluted from beads by adding 15 μl elution buffer (wash buffer II except 200 mM imidazole) and incubating at 22°C for 5 min with shaking at 1000 rpm. The elution step was repeated, and eluates were pooled and mixed with an equal volume of 2X Laemmli Sample Buffer. The results shown for all experiments that include a denaturing purification of ScIVT products are representative of at least three technical replicates (i.e., experiments conducted with independently prepared reagents).

Immunoblotting {#s4-7}
--------------

Protein samples were separated by SDS-PAGE using 12% Bolt Bis-Tris gels (Thermo Fisher Scientific) and transferred in 1X CAPS Buffer onto 0.22 micron PVDF membrane (Bio-Rad). Blots were probed with the following antibodies diluted 1:5000 in 1X TBS-T containing 5% nonfat dry milk: mouse anti-HA (RRID:[AB_627809](https://scicrunch.org/resolver/AB_627809), Santa Cruz Biotechnology \[Dallas, TX\] sc-7392), rat anti-HA high sensitivity (RRID:[AB_390918](https://scicrunch.org/resolver/AB_390918), Roche \#11867423001), mouse anti-Myc (RRID:[AB_331783](https://scicrunch.org/resolver/AB_331783), Cell Signaling Technology \[Danvers, MA\] \#2276), HRP-conjugated goat anti-mouse IgG (RRID:[AB_631736](https://scicrunch.org/resolver/AB_631736), Santa Cruz Biotechnology sc-2005), and HRP-conjugated goat anti-rat IgG (RRID:[AB_631755](https://scicrunch.org/resolver/AB_631755), Santa Cruz Biotechnology sc-2032). Blots were developed using Clarity ECL Western Blotting Substrate (Bio-Rad), and chemiluminescence was detected on a ChemiDoc Imaging System (Bio-Rad).

Protein purification {#s4-8}
--------------------

*S. cerevisiae* strain yRH101 (a gift from Stephen Bell, MIT) derived from ySC7 ([@bib8]) containing a 2 μm P~GAL1~-\[protein\]−10xHis plasmid (a gift from Bob Stroud, UCSF) was grown overnight in SC--His media containing 2% raffinose, diluted the next day, and grown for an additional night to early saturation. Protein expression was induced by adding an equal volume of Yeast-Peptone media containing 2% galactose, and cells were grown for 5 hr at 30°C. Cells were harvested by centrifugation at 3500 rpm for 6 min at 4°C, and the cell pellet was washed with water before resuspending in Lysis Buffer (20 mM HEPES-KOH pH 7.4, 500 mM KCl, 20 mM imidazole; 2 mM βME and cOmplete EDTA-free protease inhibitor cocktail \[Roche\] added just prior to use) at a ratio of 1 ml per gram of cell pellet. The resulting cell slurry was dripped into liquid nitrogen to produce frozen pellets, which were pulverized using a 6970EFM Freezer/Mill (SPEX SamplePrep) by three cycles of 12 Hz agitation for 1.67 min with 2 min cooling after each cycle. The resulting powder was briefly thawed before adding Lysis Buffer (1 mL per 1 g of powder) supplemented with additional protease inhibitors (292 μM Pepstatin, 8.4 mM Leupeptin, 1.23 mM Aprotinin, 1 mM Phenylmethylsulfonyl fluoride \[PMSF\]). Cell debris was cleared by sequential centrifugation at 14000 rpm at 4°C for 10 min and then 30 min, followed by sequential filtration through 2.7 and 1.6 μm Whatman GD/X filters (GE Healthcare Life Sciences, Marlborough, MA). His-tagged proteins were purified from lysate using Ni-NTA Sepharose beads (Qiagen) as follows. Beads (\~1 ml 50% slurry per 1 L yeast culture) were washed with water and equilibrated in Lysis Buffer. Lysate was added to semi-dry beads and rotated at 4°C for 2 hr. Beads were collected by centrifugation at 800 rpm for 3 min, resuspended in an equal volume of Lysis Buffer, loaded over a disposable Bio-Spin column (Bio-Rad), and washed once with 10 ml Lysis Buffer. The column was then washed as follows: once with 10 ml Wash Buffer (20 mM HEPES-KOH pH 7.4, 500 mM KCl, 10% glycerol, 2 mM βME) containing 20 mM imidazole and 1 mM PMSF; once with 10 ml Wash Buffer containing 20 mM imidazole; and twice with 10 ml Wash Buffer containing 50 mM imidazole. Proteins were sequentially eluted from the beads by gravity rinses as follows: once with 250 μl Wash Buffer containing 250 mM imidazole; twice with 500 μl Wash Buffer containing 250 mM imidazole; and twice with 500 μl Wash Buffer containing 500 mM imidazole. Elution fractions were analyzed by SDS-PAGE and staining with Coomassie Brilliant Blue R-250 to identify those containing the protein of interest, which were then pooled and concentrated to \~500 μl before overnight dialysis into Rqc2p/Ltn1p Storage Buffer (50 mM HEPES-KOH pH 7.4, 300 mM KOAc, 5% glycerol, 2 mM DTT) or Rqc1p Storage Buffer (20 mM HEPES-KOH pH 7.4, 500 mM KOAc, 10% glycerol, 2 mM DTT). Dialyzed protein was passed through a 0.1 μm centrifugal filter (EMD Millipore \[Hayward, CA\] \#UFC30VV00) before flash freezing in liquid nitrogen. Protein concentration was determined by both spectrophotometry using a Nanodrop 2000 (Thermo Fisher Scientific) and Coomassie staining against BSA standards.

Funding Information
===================

This paper was supported by the following grants:

-   http://dx.doi.org/10.13039/100000001National Science Foundation Graduate Research Fellowship to Beatriz A Osuna.

-   UCSF Mortiz-Heyman Discovery Fellowship Graduate Student Research Fellowship to Beatriz A Osuna.

-   UCSF Hillblom Fellowship Graduate Student Research Fellowship to Conor J Howard.

-   Searle Scholars Program 13SSP218 to Adam Frost.

-   http://dx.doi.org/10.13039/100000052NIH Office of the Director DP2GM110772 to Adam Frost.

-   UCSF Program for Breakthrough Biomedical Research funded in part by the Sandler Foundation to Adam Frost, David E Weinberg.

-   http://dx.doi.org/10.13039/100000052NIH Office of the Director DP5OD017895 to David E Weinberg.

We thank Soufiane Aboulhouda for initial work on yeast in vitro translation and David Morgan and Peter Shen for comments on the manuscript. We also thank members of the Weinberg and Frost labs, Wendy Gilbert, Jonathan Weissman, and Kamena Kostova for insightful discussions, Jonathan Asfaha for experimental advice and reagents, and Jordan Carelli and Jack Taunton for eEF1a inhibitors. We also acknowledge Raul Andino, Keith Yamamoto, Alan Frankel, and David Agard for generously sharing equipment. This work was supported by an NSF Graduate Research Fellowship and a Moritz-Heyman Discovery Fellowship (BAO), a Hillblom Graduate Research Fellowship (CJH), the Searle Scholars Program 13SSP218 (AF), NIH grant 1DP2GM110772-01 (AF), an HHMI Faculty Scholar award (AF), the UCSF Program for Breakthrough Biomedical Research funded in part by the Sandler Foundation (AF, DEW), and an NIH Director's Early Independence Award DP5OD017895 (DEW). AF is a Chan Zuckerberg Biohub Investigator.

Additional information {#s5}
======================

The authors declare that no competing interests exist.

BAO, Conceptualization, Investigation, Writing---original draft, Writing---review and editing.

CJH, Investigation, Writing---review and editing.

SK, Investigation.

AF, Conceptualization, Supervision, Funding acquisition, Writing---review and editing.

DEW, Conceptualization, Supervision, Funding acquisition, Writing---original draft, Writing---review and editing.

Additional files {#s6}
================

10.7554/eLife.27949.013

###### *S. cerevisiae* strains used in this study.

The names, genetic backgrounds, and protein expression plasmids of the strains generated and used in this study are listed in this table.

**DOI:** [http://dx.doi.org/10.7554/eLife.27949.013](10.7554/eLife.27949.013)

10.7554/eLife.27949.014

###### DNA sequences of the constructs used in this study.

**DOI:** [http://dx.doi.org/10.7554/eLife.27949.014](10.7554/eLife.27949.014)

10.7554/eLife.27949.015

Decision letter

Hinnebusch

Alan G

Reviewing editor

National Institutes of Health

,

United States

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"*in vitro* analysis of RQC activities provides insights into the mechanism and function of CAT tailing\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors and the evaluation has been overseen by a James Manley as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Alexander Mankin (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

This study reconstitutes in yeast extracts for the first time both the CAT-tailing and ubiquitylation activities of the RQC and exploits translation elongation inhibitors and mutants lacking different RQC components to probe the mechanisms and interdependencies between these two reactions. At odds with previously published work, they find that Rqc1 is required for ubiquitylation of the stalled peptides generated in their system using a non-STOP mRNA template, being defective in the rqc1Δ extract and rescued with purified Rqc1. As expected from the literature, CAT-tailing is defective in the rqc2Δ extract and can be rescued with purified WT Rqc2, but not with the D98A mutant. Unexpectedly, however, they find that the Rqc2-D98A substitution, in addition to deletion of the protein, impairs ubiquitylation as well as CAT-tailing, whereas previous studies had indicated no impact of this mutation on degradation of aberrant nascent chains in yeast cells, nor a requirement for Rqc2 in ubiquitylation of nascent chains in a mammalian extract. The authors propose instead that CAT-tailing and ubiquitylation are interdependent activities. They are also able to probe the effects of elongation inhibitors on the mechanism of CAT-tailing by the RQC complex using the preassembled, arrested 60S-peptidyl-tRNA complexes and report no effect of 40S inhibitors, as expected; nor of cycloheximide, which suggests no role for E-site binding of deacylated tRNA in CAT-tailing. They conclude that Inhibitors of the translation GTPases also had no effect, eliminating requirements for EF1 and EF2 in recruitment of charged Ala or Thr tRNAs and translocation, respectively; whereas inhibitors of the peptidyl transferase reaction did impair CAT-tailing.

Essential revisions:

All three reviewers agreed that the paper has considerable merit in uncovering an unexpected role for Rqc1 in ubiquitylation, suggesting that Rqc2-dependent CAT-tailing is required for efficient ubiquitylation, and in suggesting that CAT-tail synthesis should be achievable with only a 60S-peptidyl-tRNA complex, charged Ala and Thr tRNAs and Rqc2, without inclusion of the translation GTPases. However, certain results need to be bolstered by additional experiments or quantification of data from replicate determinations. Two of the reviewers requested additional experiments to prove that the mass-shifted material corresponds to CAT-tailed species. Quantification of the peptidyl-tRNA and CAT-tailed species from replicate experiments is needed to bolster the conclusions that the Rqc2-D98A mutant promotes mild peptidyl-tRNA hydrolysis in [Figure 1E](#fig1){ref-type="fig"}; and to demonstrate that GMPPCP does not affect peptidyl-tRNA hydrolysis in [Figure 2D](#fig2){ref-type="fig"}. Two of the reviewers also requested that you describe in some detail the modifications and critical variables in the preparation of that extract required to reconstitute RQC activities. Finally, reviewer \#1 asks you to consider an additional experiment in which aniosomycin is used to inhibit CAT-tailing and determine whether ubiquitylation is also reduced in the presence of WT Rqc2. If so, this would overcome the complication of a possible pleiotropic effect of Rqc2-D98A on both ubiquitylation and CAT-tailing. If this last experiment cannot be carried out or interpreted unambiguously, it seems necessary to include in the Discussion the possibility that the Rqc2-D98A mutation impairs ubiquitylation as well as CAT-tailing because it alters the structure of Rqc2 in a way that disrupts its scaffolding role in supporting ubiquitylation by Ltn1, in addition to disrupting CAT-tailing.

The authors also are asked to make suitable revisions to the text to address all of the less critical points raised by the referees.

Reviewer \#1:

This study reconstitutes in yeast extracts for the first time both the CAT-tailing and ubiquitylation activities of the RQC and exploits translation elongation inhibitors and mutants lacking different RQC components to probe the mechanisms and interdependencies between these two reactions. At odds with previously published work, they find that Rqc1 is required for ubiquitylation of the stalled peptides generated in their system using a non-STOP mRNA template, being defective in the rqc1D extract and rescued with purified Rqc1. As expected from the literature, CAT-tailing is defective in the rqc2Δ extract and can be rescued with purified WT Rqc2, but not with the D98A mutant. Unexpectedly, however, they find that the Rqc2-D98A substitution, in addition to deletion of the protein, impairs ubiquitylation as well as CAT-tailing, whereas previous studies had indicated no impact of this mutation on degradation of aberrant nascent chains in yeast cells, nor a requirement for Rqc2 in ubiquitylation of nascent chains in a mammalian extract. The authors propose instead that CAT-tailing and ubiquitylation are interdependent activities. They are also able to probe the effects of elongation inhibitors on the mechanism of CAT-tailing by the RQC complex using the preassembled, arrested 60S-peptidyl-tRNA complexes and find no effect of 40S inhibitors, as expected; nor of cycloheximide, which suggests no role for E-site binding of deacylated tRNA in CAT-tailing. Inhibitors of the translation GTPases also had no effect, eliminating requirements for EF1 and EF2 in recruitment of charged Ala or Thr tRNAs and translocation, respectively; whereas inhibitors of the peptidyl transferase reaction did impair CAT-tailing.

These findings are significant in uncovering an unexpected role for Rqc1 in ubiquitylation, suggesting that Rqc2-dependent CAT-tailing is required for efficient ubiquitylation, and in suggesting that CAT-tail synthesis could be achievable with only a 60S-peptidyl-tRNA complex, charged Ala and Thr tRNAs and Rqc2 without the translation GTPases.

Critical comments: My main concern is whether their finding that the Rqc2-D98A variant impairs ubiquitylation as well as CAT-tailing might arise because the D98A mutation is not as specific as believed and alters the 3-D structure of Rqc2 in a way that disrupts its scaffolding role in supporting ubiquitylation by Ltn1, in addition to disrupting CAT-tailing. If so, this would undermine the significant conclusion that CAT-tailing promotes ubiquitylation. It seems possible that they could conduct an incisive test of their model, that the efficiency of ubiquitylation is stimulated by CAT-tailing, by using aniosomycin to inhibit CAT-tailing (as they showed is possible) and then show that ubiquitylation is reduced in the presence of WT Rqc2, which would overcome the complication of a possible pleiotropic effect of Rqc2-D98A on both ubiquitylation and CAT-tailing.

Reviewer \#2:

The work of Osuna et al., explores the quality control mechanism, RQC, that operates in yeast as well as other eukaryotes. The previous groundbreaking work from the Frost lab has shown that after splitting of the stalled ribosome, the nascent chain, associated in the form of peptidyl-tRNA with the large ribosomal subunit, is elongated in a non-templated manner with the \"CAT\" tails composed of Ala and Thr residues. The CAT-tail addition was shown to be promoted by Rqc2, which interplays with the activity of other proteins of the Rqc2 complex is releasing the nascent chain and targeting it for ubiquitination and degradation. Many fundamental questions about operation of RQC remain unanswered and the current work addresses some of those questions.

The development of an *S. cerevisiae* cell-free translation system, which allowed authors recapitulate both the CAT-tail formation and nascent chain ubiquitination is an important technical advancement. Using this system the authors have generated several important new insights by showing that: 1) the peptidyl transferase center is involved in the CAT-tail formation, but likely not the translation elongation factors; 2) Rqc1 is directly involved in the nascent chain ubiquitination; 3) CAT-tailing stimulates the ubiquitination of at least some nascent chains.

The study is well performed and well presented. Most of the conclusions are convincingly supported by the experimental data. Few points, however, need clarification.

Specifically:

1\) The authors indicate that their experiments have been made possible by optimizing the in vitro translation system. However, they never commented what exactly has been optimized in comparison with the previously available protocols.

2\) Subsection "A cell-free system that recapitulates Rqc2p-mediated nascent-chain elongation" and [Figure 1C](#fig1){ref-type="fig"} (δ rqc2 panel). The upper band is probably indeed peptidyl-tRNA, but this conclusion would be much more convincing if the authors have shown that the upper band disappears upon RNase treatment.

3\) The authors present several fairly convincing, but rather indirect arguments that the \'mass-shifted\' material is generated by CAT-tailing. Demonstrating either by Northern blotting the presence exclusively of tRNA(Ala) and/or tRNA(Thr) in the \'peptidyl-tRNA\' band or by showing the incorporation of radioactive Ala or Thr residues in the tails would make this claim much stronger.

4\) Subsection "A cell-free system that recapitulates Rqc2p-mediated nascent-chain elongation"and[Figure 1E](#fig1){ref-type="fig"}. The relative intensity of peptidyl-tRNA and full product bands in the D98A mutant is comparable to that in the \'no Rqc2\' control. Therefore, the claim that the Rqc2 mutant \'promotes mild peptidyl-tRNA hydrolysis\' is questionable. Quantifying the bands (in several experimental replicates) and presenting the results of the quantification could make this claim stick.

Reviewer \#3:

The authors report the development of a yeast (*Saccharomyces cerevisiae*) in vitro translation system that recapitulates activities of the ribosome quality control complex. Translating an HA-NanoLuc reporter lacking a stop codon and lysine residues, they demonstrate generation of species that behave like a nascent peptide with a covalent attachment to a peptidyl-tRNA and like the C-terminally tailed protein species. Conversion of the peptidyl-tRNA to free peptide and generation of the C-terminally tailed protein species require Rqc2, Dom34 and Hbs1 proteins, consistent with their in vivo functions. The authors demonstrate that addition of purified Rqc2 protein allows addition of the C terminal tail and peptidyl tRNA hydrolysis. They provide direct evidence that addition of the C terminal tail is mechanistically distinct from canonical translation; it depends upon the 60S subunit of the ribosome, but not upon the 40S. They recapitulate Ltn1-dependent ubiquitination. While most of these results are expected based on in vivo analysis and other results, they are crucial to establish the validity of the system for further analyses. Furthermore, the authors also provide evidence that Rqc1 plays a role in Ltn1-mediated ubiquitination and that there is an interplay between CAT tailing and ubiquitination.

The development and characterization of the yeast system is an important contribution to the field because it allows the coupling of genetics with the biochemical analysis. Moreover, the observations about the roles of Rqc1 and CAT tailing in promoting ubiquitination are important. However, there are some points that should be addressed by the authors.

Critique:

1\) The authors consistently refer to the C-terminal additions to their polypeptide as CAT tails, but offer no evidence of this point. The Shen et al., 2015 paper used amino acid analysis as well as Edman degradation to demonstrate the addition of alanine and threonine to their in vivo reporter. This specificity is a key aspect of the RQC in yeast and differs from the mammalian system- it should be proven.

2\) In the demonstration that C-terminal additions differ from canonical translation, the authors claim that GMP-PCP (the non-hydrolyzable GTP analog) had no effect on tailing. However, this does not appear consistent with the result in the [Figure 2C](#fig2){ref-type="fig"}-in the lane with GMP-PCP, the peptidyl-tRNA band is nearly identical to the no Rqc2 lane, indicating a defect in peptidyl-tRNA hydrolysis. Also, how do the authors know that the GTP in the extract is depleted in this experiment?

3\) The authors state that Rqc1 is \"directly involved in nascent chain ubiquitination\" (subsection "Ltn1p- and Rqc1p-dependent ubiquitination in the yeast cell-free system"). It might be worth determining if the role of Rqc1 is really essential or can be substituted by addition of a higher concentration of Ltn1 protein. While the Brandman et al., paper stated that \"inclusion of Ltn1, Rqc1, and Tae2 in the RQC was not abolished by deletion of other RQC components\", it is possible that the efficiency of recruitment of the RQC is dependent upon interactions. If this is the case, a higher concentration of Ltn1 might substitute for Rqc1.

4\) One of the major contributions of this paper is the \"optimized\" in vitro translation system. It would add a lot to the paper to describe the modifications and critical variables in the preparation of that extract

10.7554/eLife.27949.016

Author response

*Essential revisions:*

*All three reviewers agreed that the paper has considerable merit in uncovering an unexpected role for Rqc1 in ubiquitylation, suggesting that Rqc2-dependent CAT-tailing is required for efficient ubiquitylation, and in suggesting that CAT-tail synthesis should be achievable with only a 60S-peptidyl-tRNA complex, charged Ala and Thr tRNAs and Rqc2, without inclusion of the translation GTPases. However, certain results need to be bolstered by additional experiments or quantification of data from replicate determinations.*

*Two of the reviewers requested additional experiments to prove that the mass-shifted material corresponds to CAT-tailed species.*

We share the reviewers' sentiment and would have liked to demonstrate that the untemplated extensions we observe in vitroare indeed composed of alanine and threonine. We have tried to accomplish this with a variety of technically challenging assays but have not been successful (more below). Fortunately, none of our conclusions depend on knowing the precise composition of the Rqc2p-dependent extensions. In the revised text, we now explicitly acknowledge the uncertainty about their amino acid composition and note that we only refer to the untemplated Rqc2p-dependent C-terminal extensions as "CAT tails" for simplicity. Nevertheless, we suspect that the extensions are bona fide CAT tails based on their having the two other characterized properties:

1\) The extensions require Rqc2p and the PTC of the 60*S* subunit but not Ltn1p, Rqc1p, or the 40*S* subunit ([Figures 1C, D, F](#fig1){ref-type="fig"}, [2B, C](#fig2){ref-type="fig"}).

2\) The extensions are untemplated and located at the C-terminus ([Figure 1B](#fig1){ref-type="fig"} and [3B](#fig3){ref-type="fig"}).

The alanine/threonine composition of the extensions is the only property of CAT tails that we were not able to demonstrate due to technical limitations of our system. Please refer to point 3) under "Reviewer \#2" and point 1) under "Reviewer \#3" for further explanation as to why the suggested experiments have not been successful or feasible. In addition to the experiments suggested by the reviewers, we have also tried the following other strategies:

Depleting Ala/Thr-charged tRNAs from CAT-tailing reactions by adding the amino alcohols of alanine and threonine (alaninol and threoninol), which inhibit tRNA charging (Hansen, Vaughan and Wang, JBC 1972; Arnez, Dock-Bregeon and Moras, JMB 1999). However, addition of any amino alcohol (e.g., serinol or isoleucinol) resulted in nonspecific inhibition of the in vitro translation reactions.

Depleting Ala/Thr-charged tRNAs from CAT-tailing reactions by omitting alanine and threonine from the ScIVT reactions. Surprisingly, omission of any one amino acid did not globally inhibit translation or CAT tailing. We suspect this is due to insufficient amino-acid depletion from the extract during dialysis, sufficient amounts of endogenous charged tRNAs in the extract, or perhaps misincorporation.

Generating more mass-shifted products for total amino acid analysis or Edman degradation. Despite our best efforts, we have not been able to generate extracts that produce enough material for these kinds of analyses (which we used successfully in the past, but only with Coomasie-stainable amounts of material obtained from in vivo yeast studies).

*Quantification of the peptidyl-tRNA and CAT-tailed species from replicate experiments is needed to bolster the conclusions that the Rqc2-D98A mutant promotes mild peptidyl-tRNA hydrolysis in [Figure 1E](#fig1){ref-type="fig"}; and to demonstrate that GMPPCP does not affect peptidyl-tRNA hydrolysis in [Figure 2D](#fig2){ref-type="fig"}.*

In the revised text, we have removed the conclusion that the Rqc2p-D98A mutant promotes mild peptidyl--tRNA hydrolysis. Given the recent revelation that eIF5A globally stimulates translation elongation and termination (Schuller et al., Mol Cell 2017), we cannot rule out the possibility that eIF5A, rather than Rqc2p-D98A alone, promotes the mild hydrolysis we observed (among other possibilities). With regards to GMP-PCP, we have removed any claims regarding the effect of GMP-PCP on peptidyl--tRNA hydrolysis. Though more peptidyl--tRNA accumulates in reactions supplemented with GMP-PCP in comparison to reactions supplemented with GTP, this may be due to inhibition of the GTPase Hbs1p, which facilitates ribosome splitting in concert with Dom34p. The persistent peptidyl--tRNA in the presence of GMP-PCP likely represents a population of 80*S* ribosomes that were not yet split at the time of GMP-PCP addition. Despite this, CAT tailed species still accumulate in the presence of GMP-PCP, indicating that GTP hydrolysis is not required for CAT tailing to occur on the available pool of 60*S*:peptidyl--tRNA.

Two of the reviewers also requested that you describe in some detail the modifications and critical variables in the preparation of that extract required to reconstitute RQC activities.

We have now included more details about the critical modifications for preparation of robustly active translation extracts that reconstitute RQC activities.

*Finally, reviewer \#1 asks you to consider an additional experiment in which aniosomycin is used to inhibit CAT-tailing and determine whether ubiquitylation is also reduced in the presence of WT Rqc2. If so, this would overcome the complication of a possible pleiotropic effect of Rqc2-D98A on both ubiquitylation and CAT-tailing. If this last experiment cannot be carried out or interpreted unambiguously, it seems necessary to include in the Discussion the possibility that the Rqc2-D98A mutation impairs ubiquitylation as well as CAT-tailing because it alters the structure of Rqc2 in a way that disrupts its scaffolding role in supporting ubiquitylation by Ltn1, in addition to disrupting CAT-tailing.*

This is an excellent suggestion, and we have conducted the proposed experiment with anisomycin using two different sets of controls. The results of these experiments are presented in the new [Figure 4D](#fig4){ref-type="fig"} (using a lysine-free mRNA as a negative control) and [Figure 4---figure supplement 3](#fig4s3){ref-type="fig"} (using the absence of Rqc2p as a negative control). We found that even in the presence of WT Rqc2p, ubiquitination dramatically decreases when CAT tailing is inhibited with anisomycin. This new data supports the conclusion that CAT tailing directly enhances Ltn1p-mediated ubiquitination and rule out the possibility that the observed reduction in ubiquitination in reactions conducted with Rqc2p(D98A) is due to pleiotropic effects imparted by the D98A mutation.

*The authors also are asked to make suitable revisions to the text to address all of the less critical points raised by the referees.*

*Reviewer \#1:*

*My main concern is whether their finding that the Rqc2-D98A variant impairs ubiquitylation as well as CAT-tailing might arise because the D98A mutation is not as specific as believed and alters the 3-D structure of Rqc2 in a way that disrupts its scaffolding role in supporting ubiquitylation by Ltn1, in addition to disrupting CAT-tailing. If so, this would undermine the significant conclusion that CAT-tailing promotes ubiquitylation. It seems possible that they could conduct an incisive test of their model, that the efficiency of ubiquitylation is stimulated by CAT-tailing, by using aniosomycin to inhibit CAT-tailing (as they showed is possible) and then show that ubiquitylation is reduced in the presence of WT Rqc2, which would overcome the complication of a possible pleiotropic effect of Rqc2-D98A on both ubiquitylation and CAT-tailing.*

We have incorporated this excellent experimental suggestion into the revised manuscript in the new [Figure 4D](#fig4){ref-type="fig"} and [Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}. Both experiments support the conclusion that CAT tailing directly enhances Ltn1p-mediated ubiquitination, as described in point \#4 under "Essential Revisions". Moreover, we think that the D98A mutation is unlikely to impair Rqc2p's scaffolding role for Ltn1p because D98 is found in the NFACT-N domain, which our prior work established is responsible for binding the A-site tRNA (Shen et al., 2015). This domain is remote from the sarcin-ricin loop where Rqc2p meets Ltn1p on the 60*S* subunit. In addition, we showed in our prior work that a structure-based mutant of the NFACT-N domain, which contained the D98A substitution, still assembled normally with the 60*S* subunit and with Ltn1p but was defective for CAT-tailing activity in vivo.

*Reviewer \#2:*

*1) The authors indicate that their experiments have been made possible by optimizing the* in vitro *translation system. However, they never commented what exactly has been optimized in comparison with the previously available protocols.*

We thank the reviewer for encouraging us to be more detailed about our protocol and have included a new emphasis on the critical modifications for preparing translation extracts that reconstitute RQC activities. Please refer to point 3) under "Essential Revisions" for further details.

*2) Subsection "A cell-free system that recapitulates Rqc2p-mediated nascent-chain elongation" and [Figure 1C](#fig1){ref-type="fig"} (δ rqc2 panel). The upper band is probably indeed peptidyl-tRNA, but this conclusion would be much more convincing if the authors have shown that the upper band disappears upon RNase treatment.*

Though we did not RNase-treat reactions conducted with *rqc2Δ* extracts to demonstrate that the \~43 kDa upper band is peptidyl--tRNA, we instead showed in [Figure 2B](#fig2){ref-type="fig"} that this species completely collapses upon treatment with puromycin. The puromycin sensitivity of the upper band unambiguously demonstrates that this species is, in fact, peptidyl--tRNA. This finding is consistent with the RNase sensitivity of the upper band (of similar molecular weight) observed at early time points in wild-type extracts, which is presented in [Figure 1B](#fig1){ref-type="fig"}.

*3) The authors present several fairly convincing, but rather indirect arguments that the \'mass-shifted\' material is generated by CAT-tailing. Demonstrating either by Northern blotting the presence exclusively of tRNA(Ala) and/or tRNA(Thr) in the \'peptidyl-tRNA\' band or by showing the incorporation of radioactive Ala or Thr residues in the tails would make this claim much stronger.*

As noted above, we agree that determining the precise composition of the untemplated extensions would be valuable and we appreciate the reviewer's experimental suggestions. Please refer to point 1) under "Essential Revisions" and point 1) under "Reviewer \#3" for explanations as to why the request for this data present a formidable challenge.

We have attempted the suggested experiment to conduct ScIVT reactions in the presence of tritiated alanine; however, we have not been able to successfully detect radiolabeled translation products (either by exposing to a phosphorscreen or by scintillation). We surmise that this is likely due to the fact that our extracts do not generate enough protein product to surpass the limit of detection for ^3^H signal given that tritium has a very low specific activity (\<50 Ci/mmol for \[^3^H\]-alanine). Further, even if we were able to demonstrate that radiolabeled alanine is incorporated into the untemplated extensions we refer to as CAT tails, this does not rule out the possibility that other amino acids are also incorporated into the extensions. Lastly, we were not able to find a source of radiolabeled threonine to use in ScIVT reactions to at least demonstrate that both alanine and threonine are present in the untemplated extensions.

We have also considered the suggested Northern blotting for tRNA(Ala) or tRNA(Thr) in the peptidyl--tRNA band. However, our finding that CAT tailing and peptidyl--tRNA hydrolysis are temporally coupled makes it difficult to stabilize CAT-tailing elongation intermediates linked to tRNA. We think the vast majority of the peptidyl--tRNA species we detect represent 60*S*:peptidyl--tRNA complexes that have yet to be engaged by the RQC. Thus, we would not expect that species to contain appreciable amounts of tRNA(Ala) or tRNA(Thr). We have tried many other experiments to demonstrate that the mass-shifted products are, in fact, composed of alanine and threonine, but none of these strategies have been successful due to the technical limitations of our system described above.

*4) Subsection "A cell-free system that recapitulates Rqc2p-mediated nascent-chain elongation"and [Figure 1E](#fig1){ref-type="fig"}. The relative intensity of peptidyl-tRNA and full product bands in the D98A mutant is comparable to that in the \'no Rqc2\' control. Therefore, the claim that the Rqc2 mutant \'promotes mild peptidyl-tRNA hydrolysis\' is questionable. Quantifying the bands (in several experimental replicates) and presenting the results of the quantification could make this claim stick.*

We have removed the conclusion that the Rqc2-D98A mutant promotes mild peptidyl--tRNA hydrolysis. Please refer to point 2) under "Essential Revisions" for further details.

*Reviewer \#3:*

*1) The authors consistently refer to the C-terminal additions to their polypeptide as CAT tails, but offer no evidence of this point. The Shen et al., 2015 paper used amino acid analysis as well as Edman degradation to demonstrate the addition of alanine and threonine to their* in vivo *reporter. This specificity is a key aspect of the RQC in yeast and differs from the mammalian system- it should be proven.*

Unfortunately, conducting amino acid analysis or Edman degradation requires a substantial amount of protein, beyond what our extracts are able to generate even after scaling up. While the specificity for alanine- and threonine-tRNAs is a key aspect of physiological CAT tails, none of our conclusions about the mechanism and function of CAT tailing are dependent on CAT-tail composition. Moreover, since CAT tails have yet to be observed in mammals, the composition of mammalian CAT tails remains unknown. Please see our earlier comments on this important point: point 1) under "Essential Revisions" and point 3) under "Reviewer \#2".

*2) In the demonstration that C-terminal additions differ from canonical translation, the authors claim that GMP-PCP (the non-hydrolyzable GTP analog) had no effect on tailing. However, this does not appear consistent with the result in the [Figure 2C](#fig2){ref-type="fig"}-in the lane with GMP-PCP, the peptidyl-tRNA band is nearly identical to the no Rqc2 lane, indicating a defect in peptidyl-tRNA hydrolysis. Also, how do the authors know that the GTP in the extract is depleted in this experiment?*

We apologize for the confusion about our GMP-PCP results and did not intend to make any claims regarding the effect of GMP-PCP on peptidyl--tRNA hydrolysis. Though more peptidyl--tRNA accumulates in reactions supplemented with GMP-PCP in comparison to reactions supplemented with GTP, this is likely due to inhibition of the GTPase Hbs1p involved in ribosome splitting. Therefore, the persistent peptidyl--tRNA in the presence of GMP-PCP likely represents protection inside 80*S* ribosomes that were not yet split at the time of GMP-PCP addition. Nevertheless, CAT-tailed species still accumulate in the presence of GMP-PCP, suggesting that GTP hydrolysis is not absolutely required for CAT tailing to occur on the available pool of 60*S*:peptidyl--tRNA.

With regards to GTP depletion, most endogenous GTP is probably removed by the extensive dialysis that we perform during preparation of IVT extracts. Indeed, in pilot experiments we found that adding exogenous GTP was essential to detect any IVT products, suggesting that most endogenous GTP had been depleted. Though we add GTP back to IVT extracts (post-dialysis) to generate RQC substrate (i.e., 60*S*:peptidyl--tRNA), the concentration of GMP-PCP used in our experiments is sufficient to entirely inhibit translation when added at the beginning of the reaction ([Figure 2D](#fig2){ref-type="fig"}, lane 3). Thus, we are confident that GMP-PCP is present at high enough concentrations to outcompete any remaining GTP and inhibit the translational GTPases.

*3) The authors state that Rqc1 is \"directly involved in nascent chain ubiquitination\" (subsection "Ltn1p- and Rqc1p-dependent ubiquitination in the yeast cell-free system"). It might be worth determining if the role of Rqc1 is really essential or can be substituted by addition of a higher concentration of Ltn1 protein. While the Brandman et al., paper stated that \"inclusion of Ltn1, Rqc1, and Tae2 in the RQC was not abolished by deletion of other RQC components\", it is possible that the efficiency of recruitment of the RQC is dependent upon interactions. If this is the case, a higher concentration of Ltn1 might substitute for Rqc1.*

We thank the reviewer for proposing this idea and have conducted the suggested experiment, which we present in the new [Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}. We found that the role of Rqc1p in facilitating nascent-chain ubiquitination could not be substituted by a higher concentration of Ltn1p.

*4) One of the major contributions of this paper is the \"optimized\"* in vitro *translation system. It would add a lot to the paper to describe the modifications and critical variables in the preparation of that extract*

We thank the reviewer for encouraging us to be more detailed about our protocol and have included a new emphasis on the critical modifications for preparing translation extracts that reconstitute RQC activities. Please refer to point 3) under "Essential Revisions" for further details.
